SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-11-020864
Filing Date
2011-04-08
Accepted
2011-04-08 07:03:33
Documents
6
Period of Report
2011-05-10
Effectiveness Date
2011-04-08

Document Format Files

Seq Description Document Type Size
1 v217576_def14a.htm DEF 14A 442512
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_nilethera-pms.jpg GRAPHIC 19384
4 GRAPHIC spacer.gif GRAPHIC 43
5 GRAPHIC v217576_proxycard-1.jpg GRAPHIC 240752
6 GRAPHIC v217576_proxycard-2.jpg GRAPHIC 273118
  Complete submission text file 0001144204-11-020864.txt   1179228
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 650-458-2678
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34058 | Film No.: 11747527
SIC: 2834 Pharmaceutical Preparations